arginine and Parkinson Disease

arginine has been researched along with Parkinson Disease in 68 studies

Research

Studies (68)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (8.82)	18.7374
1990's	6 (8.82)	18.2507
2000's	33 (48.53)	29.6817
2010's	18 (26.47)	24.3611
2020's	5 (7.35)	2.80

Authors

Authors	Studies
Fazli-Tabaei, S; Khakpai, F; Zarrindast, MR	1
Iguchi, Y; Kitagawa, T; Komatsu, T; Mitsumura, H; Murakami, H; Omoto, S; Saito, M; Sakai, K; Sato, T; Shiraishi, T; Takatsu, H; Umehara, T	1
Bernal-Casas, D; Cascante, M; Franco, R; González-Subías, M; Lillo, A; Marin, S; Navarro, G; Sánchez-Navés, J; Serrano-Marín, J	1
Bansal, G; Bansal, Y; Minhas, R	1
Khan, AR; Purlyte, E; Waschbüsch, D	1
Conedera, S; Daida, K; Funayama, M; Hattori, N; Ikeda, A; Li, Y; Matsushima, T; Nakajima, S; Nishioka, K; Oyama, G; Yoshino, H	1
Ernst, L; Giesert, F; Glasl, L; Hölter, SM; Piccoli, G; Stautner, C; Vogt Weisenhorn, DM; Wurst, W; Zerle, J; Zimprich, A	1
Blackie, J; Chu, S; Ellis, M; Hayes, M; Kennerson, M; Lubomski, M; Nicholson, G; O'Sullivan, JD	1
Bindoff, LA; Haugarvoll, K	1
Alappat, L; Awad, AB; Bradford, PG; Virarkar, M	1
Chen, CM; Chen, WL; Lee, CM; Lee-Chen, GJ; Lin, CH; Wang, HC; Wu, YR	1
Barandiaran, M; Bergareche, A; Estanga, A; Gorostidi, A; Lopez de Munain, A; Marti-Masso, JF; Mondragon, E; Rodriguez-Oroz, MC; Ruiz-Martinez, J	1
Berbellini, A; Cozzolino, V; De Michele, G; Gobbato, R; Manca, A; Paci, C; Peluso, S; Pianese, L; Ragno, M; Sanguigni, S	1
Cakmak, S; Cumhur Cure, M; Cure, E; Kirbas, A; Kirbas, S; Tufekci, A; Yazici, T	1
Cao, M; Cen, SS; Chan, P; Dan, XJ; Gu, ZQ; Li, DW; Li, Y; Zhang, H	1
Bardien, S; Carr, J; Keyser, R; Lombard, D; Yako, Y	1
Abdo, WF; Bloem, BR; Verbeek, MM	1
Ross, OA; Tan, EK; Tan, LC; Tang, M; Wu, RM; Wu, YR; Zhao, Y	1
Cannas, A; Corongiu, D; Cuccu, S; Floris, G; Marrosu, F; Marrosu, MG; Murru, MR; Rolesu, M; Sardu, C; Solla, P; Tranquilli, S	1
Gómez-Esteban, JC; Zarranz, JJ	1
Ascherio, A; Gao, X; Han, J; Schwarzschild, MA; Simon, KC	1
Edwards, KL; Hutter, CM; Izumi, Y; Kaji, R; Kawakami, H; Larson, EB; Lopez, AN; Maruyama, H; Mata, IF; Morino, H; Oda, M; Schellenberg, GD; Tsuang, DW; Ujike, H; Yamamoto, M; Yearout, D; Zabetian, CP	1
Elahi, E; Farboodi, N; Fazlali, Z; Ghazavi, F; Ghorashi, SA; Parsa, K; Ronaghi, M; Sadeghi, H; Shahidi, GA; Shojaee, S; Sina, F	1
An, X; Burgunder, JM; Chen, W; Gou, Y; Mao, X; Peng, R; Wang, Y; Wu, Y; Xu, Y; Yuan, G; Zhang, J; Zhang, Z	1
Bolaño, MJ; Ferrer, I; Gorostidi, A; López de Munain, A; Martí-Massó, JF; Moreno, F; Ruiz, I; Ruiz-Martínez, J	1
Cho, JH; Jeon, BS; Kim, HJ; Kim, JM; Kim, JS; Lee, JY; Park, SS; Shin, ES	1
Fujimoto, T; Fukushima, W; Fukuyama, H; Hirota, Y; Kawamura, N; Kiyohara, C; Koyanagi, M; Miki, T; Miyake, Y; Nagai, M; Oeda, T; Sakae, N; Sasaki, S; Shirasawa, S; Tanaka, K; Tsuboi, Y; Yamada, T	1
Alzualde, A; Bergareche, A; Gómez-Esteban, JC; Gorostidi, A; Ibañez, B; López de Munain, A; Martí Massó, JF; Moreno, F; Otaegui, D; Ruiz-Martínez, J	1
Chabeauti, PY; Chalon, S; Decressac, M; Frangeul, L; Gaillard, A; Herzog, H; Jaber, M; Pain, S; Thiriet, N; Vergote, J	1
Burguera, JA; Ezquerra, M; Gaig, C; Irigoyen, J; Lorenzo, E; Lorenzo-Betancor, O; Luquin, MR; Martí, MJ; Obeso, JA; Pastor, MA; Pastor, P; Perez-Tur, J; Rodríguez-Oroz, MC; Ross, OA; Samaranch, L; Soto-Ortolaza, AI; Tolosa, E; Valldeoriola, F	1
Camargos, ST; Cardoso, F; DiMauro, S; Gurgel-Giannetti, J; Hirano, M	1
Augustin, J; Ayrignac, X; Campion, D; Clanet, M; Coutant, S; Defebvre, L; Frébourg, T; Guyant-Maréchal, L; Hannequin, D; Krystkowiak, P; Labauge, P; Le Ber, I; Lefaucheur, R; Legallic, S; Maltête, D; Martinaud, O; Nicolas, G; Pariente, J; Pottier, C; Rousseau, S; Rovelet-Lecrux, A; Vaschalde, Y	1
Burgunder, J; Cao, B; Chen, K; Chen, X; Chen, Y; Guo, X; Huang, R; Li, J; Shang, HF; Song, W; Zhao, B	1
Clarimon, J; Eerola, J; Hellström, O; Singleton, A; Tienari, PJ	1
Barone, P; Colao, A; De Michele, G; Faggiano, A; Filla, A; Lombardi, G; Pellecchia, MT; Pivonello, R; Salvatore, E	1
Ezquerra, M; Gaig, C; Marti, MJ; Muñoz, E; Tolosa, E; Valldeoriola, F	1
Abbruzzese, G; Barone, P; Bonuccelli, U; Bracco, F; Colao, A; Donati, E; Eleopra, R; Epifanio, A; Longo, K; Lucetti, C; Manfredi, M; Marchese, R; Marconi, R; Morgante, L; Pellecchia, MT; Pivonello, R; Scaravilli, T; Sensi, M; Spampani, A; Zappia, M	1
López de Munain, A; Martí-Massó, JF; Martínez-Gil, A; Paisán-Ruiz, C; Pérez-Tur, J; Ruiz-Martínez, J; Sáenz, A; Sánchez-Mut, JV; Simón-Sánchez, J; Singleton, AB	1
Latsoudis, H; Plaitakis, A; Spanaki, C	1
Farrer, MJ; Gibson, JM; Gosal, D; Haugarvoll, K; Lynch, T; Ross, OA	1
Deng, H; Guo, Y; Huang, M; Hunter, CB; Jankovic, J; Le, W; Xie, W	1
Foroud, T; Halter, CA; Marek, DK; Nichols, WC; Pankratz, N; Pauciulo, MW; Rudolph, A; Shults, CW; Wojcieszek, J	1
Hiner, BC	1
Barone, P; Colao, A; Pellecchia, MT; Pivonello, R	1
Aasly, JO; Adler, CH; Blazquez, M; Farrer, MJ; Gibson, JM; Gwinn-Hardy, K; Haugarvoll, K; Hulihan, MM; Kachergus, J; Lynch, T; Mata, IF; Ross, OA; Stone, JT; Toft, M; White, LR	1
Dächsel, JC; Farrer, MJ; Haugarvoll, K; Hulihan, MM; Lin, CH; Ross, OA; Stone, JT; Wu, RM	1
Fook-Chong, S; Tan, EK; Yi, Z	1
Fook-Chong, S; Lee, J; Lim, HQ; Liu, JJ; Pavanni, R; Tan, EK; Tan, L; Wong, MC; Yuen, Y; Zhao, Y	1
Abbruzzese, G; Barone, P; Bonuccelli, U; Colao, A; Cossu, G; Donati, E; Eleopra, R; Epifanio, A; Longo, K; Lucetti, C; Manfredi, M; Marchese, R; Marconi, R; Morgante, L; Pellecchia, MT; Petrone, A; Pivonello, R; Scaravilli, T; Sensi, M	1
Chan, DK; Clarke, R; Fang, ZM; Hattori, N; Kwok, JB; Mok, V; Ng, PW; Schofield, PR; Wong, L; Yeung, J	1
An, XK; Burgunder, JM; Chen, WJ; Gou, YR; Li, T; Peng, R; Wang, YC; Wu, Y; Xu, YM; Yuan, GG; Zhang, JH; Zhang, ZJ	1
Carver, JA; Ecroyd, H	1
Schapira, AH; Tan, EK	1
Benecke, R; Berg, D; Bonifati, V; Brown, L; Cras, P; De Deyn, PP; Engelborghs, S; Farrer, MJ; Foroud, T; Gaig, C; Gasser, T; Gibson, JM; Goldwurm, S; Guidi, M; Hagenah, J; Haugarvoll, K; Kachergus, JM; Klein, C; Nichols, WC; Nuytemans, K; Pals, P; Pickut, B; Rademakers, R; Riboldazzi, G; Ross, OA; Samii, A; Tan, EK; Theuns, J; Tolosa, E; Uitti, RJ; Van Broeckhoven, C; Walter, U; Wszolek, ZK; Zabetian, CP	1
Ichikawa, Y; Iwahashi, K; Matsuo, Y; Takeuchi, H; Tsuneoka, Y	1
Baig, S; Bednar, I; Forsberg, G; Qureshi, GA; Siden, A; Södersten, P	1
Castellani, R; Perry, G; Richey, PL; Smith, MA	1
Boni, S; Caffarra, P; Chiodera, P; Coiro, V; Saginario, A; Scaglioni, A; Volpi, R	1
Kostowski, W; Krzaścik, P	1
Akhmedova, S; Anisimov, S; Schwartz, E; Yakimovsky, A	1
Bergmans, PL; Kuiper, MA; Scheltens, P; Teerlink, T; Visser, JJ; Wolters, EC	1
Barone, P; Colao, AM; De Michele, G; Faggiano, A; Filla, A; Pellecchia, MT; Pivonello, R; Salvatore, E	1
Chase, TN; Nagano, Y; Tsubaki, T	1
Johnson, SE; Norman, N; Sjaastad, O	1
Abe, K; Nagata, N; Nakamura, E; Saito, S; Tanaka, K	1
Bana, R; Cavagnini, F; Peracchi, M; Pontiroli, AE; Raggi, U; Scotti, G	1
Root, AW; Russ, RD	1
Bruck, J; Gerstenbrand, F; Gnad, H; Gründig, E; Prosenz, P; Teuflmayr, R	1

Reviews

3 review(s) available for arginine and Parkinson Disease

Article	Year
Inducible nitric oxide synthase inhibitors: A comprehensive update. Medicinal research reviews, 2020, Volume: 40, Issue:3 Topics: Alzheimer Disease; Amidines; Animals; Arginine; Arthritis, Rheumatoid; Catalytic Domain; Chalcones; Chemistry, Pharmaceutical; Drug Design; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Imidazoles; Inflammatory Bowel Diseases; Inhibitory Concentration 50; Macrophages; Mice; Multiple Sclerosis; Nitric Oxide; Nitric Oxide Synthase Type II; Parkinson Disease; Steroids	2020
L-arginine and nitric oxide in CNS function and neurodegenerative diseases. Critical reviews in food science and nutrition, 2013, Volume: 53, Issue:11 Topics: Alzheimer Disease; Animals; Arginine; Central Nervous System; Central Nervous System Diseases; Diet; Humans; Neurodegenerative Diseases; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease	2013
Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. Clinical medicine & research, 2006, Volume: 4, Issue:4 Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; Diagnosis, Differential; Growth Hormone; Humans; Multiple System Atrophy; Parkinson Disease	2006

Other Studies

65 other study(ies) available for arginine and Parkinson Disease

Article	Year
Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis. Neurobiology of learning and memory, 2021, Volume: 186 Topics: Adrenergic Agents; Animals; Anxiety; Arginine; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Male; Memory; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Parkinson Disease; Quinpirole; Receptors, Dopamine D2; Sulpiride	2021
The association between urinary pentosidine levels and cognition in drug-naïve patients with Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:11 Topics: Arginine; Cognition; Humans; Lysine; Parkinson Disease	2022
A metabolomics study in aqueous humor discloses altered arginine metabolism in Parkinson's disease. Fluids and barriers of the CNS, 2023, Dec-04, Volume: 20, Issue:1 Topics: Aqueous Humor; Arginine; Biomarkers; Humans; Levodopa; Parkinson Disease; Putrescine	2023
Dual arginine recognition of LRRK2 phosphorylated Rab GTPases. Biophysical journal, 2021, 05-04, Volume: 120, Issue:9 Topics: Arginine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Parkinson Disease; Phosphorylation; rab GTP-Binding Proteins	2021
A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease. Parkinsonism & related disorders, 2017, Volume: 34 Topics: Arginine; DNA-Binding Proteins; Histidine; Humans; Mitochondrial Proteins; Mutation; Parkinson Disease; Transcription Factors	2017
The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse. Neurobiology of disease, 2017, Volume: 105 Topics: Animals; Arginine; Cysteine; Disease Models, Animal; Exploratory Behavior; Gait; Genotype; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mice; Mice, Transgenic; Motor Activity; Parkinson Disease; Point Mutation; Prodromal Symptoms; Recognition, Psychology; Smell; Swimming; Synaptophysin; Synaptotagmin I; Tyrosine 3-Monooxygenase	2017
A novel Parkinson's disease risk variant, p. W378R, in the Gaucher's disease GBA gene. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:10 Topics: Adult; Aged; Arginine; Family Health; Female; Gaucher Disease; Glucosylceramidase; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Tryptophan	2018
A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype. Journal of Parkinson's disease, 2011, Volume: 1, Issue:1 Topics: Adult; Arginine; Heterozygote; Humans; Male; Mutation, Missense; Parkinson Disease; Phenotype; Proline; Tyrosine 3-Monooxygenase	2011
Variant R244H in Na+/Mg2+ exchanger SLC41A1 in Taiwanese Parkinson's disease is associated with loss of Mg2+ efflux function. Parkinsonism & related disorders, 2014, Volume: 20, Issue:6 Topics: Adult; Arginine; Asian People; Case-Control Studies; Cation Transport Proteins; Cohort Studies; DNA Mutational Analysis; Female; Genetic Variation; HEK293 Cells; Histidine; Humans; Magnesium; Male; Parkinson Disease; Taiwan; Transfection	2014
Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2. Parkinsonism & related disorders, 2014, Volume: 20, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Arginine; Case-Control Studies; Cognition Disorders; Female; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Neuropsychological Tests; Parkinson Disease; Protein Serine-Threonine Kinases; Severity of Illness Index	2014
Parkinsonism in a pair of monozygotic CADASIL twins sharing the R1006C mutation: a transcranial sonography study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2016, Volume: 37, Issue:6 Topics: Aged; Arginine; CADASIL; Cysteine; Humans; Male; Mutation; Parkinson Disease; Receptor, Notch3; Twins, Monozygotic; Ultrasonography, Doppler, Transcranial	2016
Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease. Acta clinica Belgica, 2016, Volume: 71, Issue:2 Topics: Aged; Arginine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Male; Middle Aged; Nitric Oxide; Parkinson Disease	2016
Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant. Neuroscience bulletin, 2016, Volume: 32, Issue:6 Topics: Aged; Aged, 80 and over; Arginine; Female; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Polymorphism, Single Nucleotide; Sensory Thresholds	2016
Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease. Parkinsonism & related disorders, 2009, Volume: 15, Issue:2 Topics: Adolescent; Adult; Aged; Arginine; Asparagine; Aspartic Acid; Cysteine; DNA Mutational Analysis; Exons; Female; Gene Frequency; Heterozygote; Humans; Male; Middle Aged; Parkinson Disease; Point Mutation; Sequence Deletion; South Africa; Ubiquitin-Protein Ligases; Young Adult	2009
The accuracy of the arginine growth hormone test in Parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2008, Jul-15, Volume: 23, Issue:9 Topics: Arginine; Body Mass Index; Human Growth Hormone; Humans; Parkinson Disease	2008
Lrrk2 R1628P in non-Chinese Asian races. Annals of neurology, 2008, Volume: 64, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Arginine; Asian People; Female; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Proline; Protein Serine-Threonine Kinases	2008
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients. Parkinsonism & related disorders, 2009, Volume: 15, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arginine; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Glycine; Humans; Italy; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Population Groups; Protein Serine-Threonine Kinases; Serine; Tomography, Emission-Computed, Single-Photon	2009
LRRK2 mutations in Basque patients with Parkinson's disease. The Lancet. Neurology, 2008, Volume: 7, Issue:10 Topics: Arginine; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Serine; Spain	2008
Genetic determinants of hair color and Parkinson's disease risk. Annals of neurology, 2009, Volume: 65, Issue:1 Topics: Adolescent; Age Factors; Arginine; Case-Control Studies; Cysteine; Female; Follow-Up Studies; Genetic Determinism; Genotype; Hair Color; Humans; Male; Parkinson Disease; Polymorphism, Genetic; Receptor, Melanocortin, Type 1; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Young Adult	2009
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, May-15, Volume: 24, Issue:7 Topics: Aged; Arginine; DNA Mutational Analysis; Exons; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Meta-Analysis as Topic; Middle Aged; Models, Statistical; Molecular Sequence Data; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Risk Factors	2009
A clinic-based screening of mutations in exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's disease patients. Movement disorders : official journal of the Movement Disorder Society, 2009, May-15, Volume: 24, Issue:7 Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Arginine; Child; Cysteine; DNA Mutational Analysis; Exons; Female; Genetic Testing; Humans; Iran; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Young Adult	2009
LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Movement disorders : official journal of the Movement Disorder Society, 2009, Oct-15, Volume: 24, Issue:13 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Asian People; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Protein Serine-Threonine Kinases; Young Adult	2009
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2. Movement disorders : official journal of the Movement Disorder Society, 2009, Oct-15, Volume: 24, Issue:13 Topics: Aged; Arginine; beta-Crystallin A Chain; DNA Mutational Analysis; Glutamine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mutation; Nerve Tissue Proteins; Parkinson Disease; Protein Serine-Threonine Kinases; Substantia Nigra; tau Proteins; Ubiquitin	2009
The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population. Parkinsonism & related disorders, 2010, Volume: 16, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Arginine; Chi-Square Distribution; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Korea; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Risk Factors; Young Adult	2010
LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: a case-control study in Japan. Journal of the neurological sciences, 2010, Oct-15, Volume: 297, Issue:1-2 Topics: Aged; Arginine; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Glycine; Humans; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Retrospective Studies; Risk Factors; Smoking; Surveys and Questionnaires	2010
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain). Movement disorders : official journal of the Movement Disorder Society, 2010, Oct-30, Volume: 25, Issue:14 Topics: Age Factors; Aged; Aged, 80 and over; Arginine; Family; Female; Glycine; Humans; Incidence; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Penetrance; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Spain	2010
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. Neurobiology of aging, 2012, Volume: 33, Issue:9 Topics: Adrenergic Agents; Analysis of Variance; Animals; Animals, Newborn; Arginine; Autoradiography; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Enzyme Inhibitors; Female; Functional Laterality; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroblastoma; Neurodegenerative Diseases; Neuropeptide Y; Neuroprotective Agents; Nortropanes; Oligopeptides; Oxidopamine; Parkinson Disease; Protein Binding; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Substantia Nigra; Tyrosine 3-Monooxygenase	2012
LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:1 Topics: Adult; Age Factors; Aged; Arginine; Chromosomes, Human, Pair 12; DNA Mutational Analysis; Family Health; Female; Genetic Linkage; Haplotypes; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Serine	2012
POLG1 Arg953Cys mutation: expanded phenotype and recessive inheritance in a Brazilian family. Muscle & nerve, 2012, Volume: 45, Issue:3 Topics: Adult; Arginine; Brazil; Cardiomyopathies; Cysteine; Depression; DNA Mutational Analysis; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Electromyography; Female; Gait Disorders, Neurologic; Humans; Male; Muscle, Skeletal; Mutation; Neural Conduction; Ophthalmoplegia, Chronic Progressive External; Parkinson Disease; Phenotype; Succinate Dehydrogenase	2012
Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology, 2013, Jan-08, Volume: 80, Issue:2 Topics: Adult; Aged; Amino Acid Substitution; Arginine; Basal Ganglia Diseases; Calcinosis; Child; Databases, Genetic; Exome; Female; Humans; Leucine; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurologic Examination; Parkinson Disease; Pedigree; Polymerase Chain Reaction; Proline; Receptor, Platelet-Derived Growth Factor beta; Tomography, X-Ray Computed; Tryptophan	2013
VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China. Neurobiology of aging, 2013, Volume: 34, Issue:6 Topics: Adult; Aged; Arginine; Asparagine; Aspartic Acid; Case-Control Studies; China; Eukaryotic Initiation Factor-4G; Female; Histidine; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Vesicular Transport Proteins; Young Adult	2013
Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population. Neuroscience letters, 2004, Sep-02, Volume: 367, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Arginine; Aryldialkylphosphatase; Case-Control Studies; DNA Mutational Analysis; Female; Finland; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Leucine; Male; Methionine; Middle Aged; Parkinson Disease; Polymorphism, Genetic	2004
Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia. Clinical endocrinology, 2005, Volume: 62, Issue:4 Topics: Arginine; Case-Control Studies; Clonidine; Diagnosis, Differential; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Sensitivity and Specificity; Spinocerebellar Degenerations; Stimulation, Chemical; Sympatholytics	2005
LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Archives of neurology, 2006, Volume: 63, Issue:3 Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Arginine; Child; Child, Preschool; DNA Mutational Analysis; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Pedigree; Protein Serine-Threonine Kinases; Serine; Spain	2006
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test. Annals of neurology, 2006, Volume: 60, Issue:5 Topics: Antiparkinson Agents; Arginine; Diagnosis, Differential; Female; Human Growth Hormone; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; ROC Curve; Severity of Illness Index	2006
Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: Aged; Arginine; Chromosomes, Human, Pair 12; Demography; DNA Mutational Analysis; Family Health; Female; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Spain	2006
LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP. Neurology, 2006, Oct-24, Volume: 67, Issue:8 Topics: Age of Onset; Aged; Aged, 80 and over; Arginine; Cohort Studies; Dementia; Disease Progression; Female; Genetic Predisposition to Disease; Greece; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Pedigree; Protein Serine-Threonine Kinases; Supranuclear Palsy, Progressive	2006
Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred. Movement disorders : official journal of the Movement Disorder Society, 2007, Jan-15, Volume: 22, Issue:2 Topics: Arginine; Binding Sites; Disease Progression; Glycine; Histidine; Humans; Ireland; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Penetrance; Point Mutation; Protein Serine-Threonine Kinases	2007
Genetic analysis of LRRK2 mutations in patients with Parkinson disease. Journal of the neurological sciences, 2006, Dec-21, Volume: 251, Issue:1-2 Topics: Adult; Aged; Arginine; Chromosomes, Human, Pair 12; DNA Mutational Analysis; Female; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Serine	2006
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation. Movement disorders : official journal of the Movement Disorder Society, 2007, Jan-15, Volume: 22, Issue:2 Topics: Adenine Nucleotide Translocator 1; Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Carrier Proteins; Diagnosis, Differential; Female; Genetic Variation; Genotype; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Point Mutation; Protein Serine-Threonine Kinases	2007
Differential diagnosis of Parkinson's disease: a new blood test? Clinical medicine & research, 2006, Volume: 4, Issue:4 Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; Diagnosis, Differential; Growth Hormone; Humans; Multiple System Atrophy; Parkinson Disease	2006
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2007, Feb-15, Volume: 22, Issue:3 Topics: Aged; Aged, 80 and over; Arginine; Case-Control Studies; Female; Genetic Predisposition to Disease; Glutamine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases	2007
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism & related disorders, 2007, Volume: 13, Issue:2 Topics: Aged; Arginine; Asian People; Female; Genetic Predisposition to Disease; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Risk Factors	2007
Comparing LRRK2 Gly2385Arg carriers with noncarriers. Movement disorders : official journal of the Movement Disorder Society, 2007, Apr-15, Volume: 22, Issue:5 Topics: Aged; Arginine; Female; Genetic Carrier Screening; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation, Missense; Neurologic Examination; Parkinson Disease; Protein Serine-Threonine Kinases	2007
Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians. Movement disorders : official journal of the Movement Disorder Society, 2007, Sep-15, Volume: 22, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Arginine; Asia, Southeastern; Chi-Square Distribution; Female; Gene Frequency; Genotype; Glycine; Humans; India; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Odds Ratio; Parkinson Disease; Protein Serine-Threonine Kinases; Risk Factors	2007
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms. Movement disorders : official journal of the Movement Disorder Society, 2008, Jan-30, Volume: 23, Issue:2 Topics: Aged; Analysis of Variance; Arginine; Female; Human Growth Hormone; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; ROC Curve	2008
PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:5 Topics: Adult; Age of Onset; Arginine; Asian People; Cysteine; DNA Mutational Analysis; Female; Hong Kong; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Ubiquitin-Protein Ligases	2008
LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. European journal of neurology, 2008, Volume: 15, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Arginine; Asian People; Chi-Square Distribution; China; Female; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Risk Factors	2008
The effect of small molecules in modulating the chaperone activity of alphaB-crystallin against ordered and disordered protein aggregation. The FEBS journal, 2008, Volume: 275, Issue:5 Topics: alpha-Crystallin B Chain; alpha-Synuclein; Amyloid; Animals; Arginine; Caseins; Cattle; Cytoprotection; Guanidine; Hot Temperature; Humans; Insulin; Lactalbumin; Mutation; Parkinson Disease	2008
Uniting Chinese across Asia: the LRRK2 Gly2385Arg risk variant. European journal of neurology, 2008, Volume: 15, Issue:3 Topics: Arginine; Asia; Asian People; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Parkinson Disease; Protein Serine-Threonine Kinases	2008
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology, 2008, Apr-15, Volume: 70, Issue:16 Pt 2 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Cysteine; DNA Mutational Analysis; Female; Glycine; Haplotypes; Humans; Internationality; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Protein Serine-Threonine Kinases; Serine	2008
A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. Journal of biochemistry, 1993, Volume: 114, Issue:2 Topics: Arginine; Base Sequence; Cysteine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Deoxyribonucleases, Type II Site-Specific; Genotype; Homozygote; Humans; Japan; Mixed Function Oxygenases; Molecular Sequence Data; Mutation; Parkinson Disease; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length	1993
Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport, 1995, Aug-21, Volume: 6, Issue:12 Topics: Aged; Arginine; Female; Humans; Levodopa; Male; Middle Aged; Nitric Oxide; Nitrites; Parkinson Disease; Treatment Outcome	1995
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain research, 1996, Oct-21, Volume: 737, Issue:1-2 Topics: Aged; Aged, 80 and over; Arginine; Cerebral Cortex; Cross-Linking Reagents; Glycation End Products, Advanced; Glycosylation; Heme Oxygenase (Decyclizing); Humans; Immunohistochemistry; Locus Coeruleus; Lysine; Microscopy, Immunoelectron; Middle Aged; Neurons; Norleucine; Oxidative Stress; Parkinson Disease; Pyrroles; Substantia Nigra	1996
Defective 5-HT 1-receptor-mediated neurotransmission in the control of growth hormone secretion in Parkinson's disease. Neuropsychobiology, 1997, Volume: 35, Issue:2 Topics: Aged; Analysis of Variance; Arginine; Case-Control Studies; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pituitary Gland; Serotonin Receptor Agonists; Sumatriptan	1997
Nitric oxide donors antagonize N-nitro-L-arginine and haloperidol catalepsy: potential implication for the treatment of Parkinsonism? Polish journal of pharmacology, 1997, Volume: 49, Issue:4 Topics: Animals; Arginine; Catalepsy; Disease Models, Animal; Haloperidol; Male; Molsidomine; Nitric Oxide Synthase; Nitroarginine; Parkinson Disease; Rats; Rats, Wistar; Vasodilator Agents	1997
Gln --> Arg 191 polymorphism of paraoxonase and Parkinson's disease. Human heredity, 1999, Volume: 49, Issue:3 Topics: Aged; Alleles; Amino Acid Substitution; Arginine; Aryldialkylphosphatase; Base Sequence; Deoxyribonucleases, Type I Site-Specific; DNA; DNA Restriction Enzymes; Esterases; Gene Frequency; Genotype; Glutamine; Humans; Middle Aged; Parkinson Disease; Polymorphism, Genetic	1999
L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:2 Topics: Aged; Alzheimer Disease; Arginine; Citrulline; Glutamic Acid; Humans; Middle Aged; Multiple System Atrophy; Neurons; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease	2000
Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; Diagnosis, Differential; Drug Administration Schedule; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Multiple System Atrophy; Parkinson Disease; Spinocerebellar Degenerations	2001
Endocrinologic regulation of carbohydrate metabolism. Amyotrophic lateral sclerosis and Parkinsonism-dementia on Guam. Archives of neurology, 1979, Volume: 36, Issue:4 Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Arginine; Blood Glucose; Charcot-Marie-Tooth Disease; Female; Growth Hormone; Guam; Humans; Insulin; Male; Middle Aged; Muscular Dystrophies; Parkinson Disease	1979
Decreased arginine-induced HGH response during L-dopa therapy in parkinsonian patients. Acta endocrinologica, 1974, Volume: 77, Issue:4 Topics: Adult; Arginine; Depression, Chemical; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Radioimmunoassay; Stimulation, Chemical	1974
Effect of L-dopa on anterior pituitary hormone release in man. Endocrinologia japonica, 1972, Volume: 19, Issue:5 Topics: Adult; Aged; Arginine; Blood Glucose; Dihydroxyphenylalanine; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Insulin; Luteinizing Hormone; Male; Menstruation; Middle Aged; Parkinson Disease; Pituitary Hormones, Anterior; Stimulation, Chemical; Thyrotropin	1972
Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients. The Journal of endocrinology, 1972, Volume: 54, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Arginine; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Dopamine; Female; Growth Hormone; Humans; Hypoglycemia; Injections, Intravenous; Insulin; Male; Middle Aged; Parkinson Disease; Secretory Rate	1972
Effect of L-dihydroxyphenylalanine upon serum growth hormone concentrations in children and adolescents. The Journal of pediatrics, 1972, Volume: 81, Issue:4 Topics: Adolescent; Adult; Aged; Arginine; Blood Glucose; Child; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Insulin; Male; Middle Aged; Parkinson Disease; Pituitary Gland	1972
[The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals]. Deutsche Zeitschrift fur Nervenheilkunde, 1969, Volume: 196, Issue:3 Topics: Alanine Transaminase; Arginine; Aspartate Aminotransferases; Dihydroxyphenylalanine; Glutamine; Glycine; Humans; Injections, Intravenous; Ketoglutaric Acids; Oxaloacetates; Parkinson Disease	1969